Early prostate cancer detection, screening: No benefit for men with low baseline PSA value
Monday, September 13, 2010 - 05:56
in Health & Medicine
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection...